Annals On Call Podcast
Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.
Latest episodes
Nov 16, 2020 • 26min
Does Bariatric Surgery Decrease Mortality?
Dr. Centor discusses the long-term outcomes of bariatric surgery with Dr. Christina Wee.
Nov 5, 2020 • 25min
Remdesivir as Treatment for COVID-19
Dr. Centor discusses the American College of Physicians' recommendations for the use of remdesivir in the treatment of COVID-19 with Dr. Rebecca Andrews.
Nov 2, 2020 • 25min
Should Race Be Part of Glomerular Filtration Rate Estimation?
Dr. Centor discusses the rationale for and against incorporating race into equations used to estimate glomerular filtration rate with Dr. Ashwini R. Sehgal.
Oct 19, 2020 • 22min
Underdiagnosis of Primary Aldosteronism
Dr. Centor discusses the diagnosis of primary aldosteronism with Dr. Jenifer M. Brown.
Oct 5, 2020 • 20min
Restoring the Story to Health Records
Dr. Centor discusses the history and function of clinical notes in electronic health records and ways to improve them with Dr. Heather E. Gantzer.
Sep 14, 2020 • 28min
Assessing Renal Damage With Urinary Albumin or Protein
Dr. Centor discusses the use of urinary albumin or protein to screen for and stage chronic kidney disease with Dr. Joseph A. Vassalotti.
Aug 31, 2020 • 23min
Regulatory T Cells: Treatment for COVID-19?
Dr. Centor discusses the potential use of regulatory T cells to treat patients with acute respiratory distress syndrome associated with COVID-19 with Dr. Franco R. D.Alessio.
Aug 12, 2020 • 29min
Annals On Call - COVID Potpourri
Dr. Centor discusses challenges to diagnosing COVID-19 with Dr. Jeanne Marrazzo.
Aug 3, 2020 • 24min
Annals On Call - Hypertension in the Hospital
Dr. Centor discusses the management of hypertension in hospitalized patients with Drs. Timothy S. Anderson and Charlie M. Wray.
Jul 21, 2020 • 20min
Why Do Patients Develop Anemia With Chronic Inflammation?
Dr. Centor discusses inflammation-associated anemia and its response to interluekin-1ß inhibition with canakinumab in CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) with trial investigator Dr. Mounica Vallurupalli.
